Amniotic membrane use for management of corneal limbal stem cell deficiency

Alfonso L. Sabater, Victor L Perez Quinones

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Purpose of review: The current article reviews the most recent surgical techniques for management of corneal limbal stem cell deficiency (LSCD) using amniotic membrane tissue. Recent findings: Early successes with amniotic membrane transplantation (AMT) for the treatment of ocular surface disorders have encouraged clinicians to investigate new applications. The use of AMT as a temporary patch in emergency cases in which LSCD may develop has considerably improved the prognosis of these patients. Amniotic membrane does not have stem cells of its own, but it supports regeneration of limbal epithelial stem cells (LESCs). Similarly, the combination of AMT with classic surgical techniques has enhanced the surgical success rates in most case series. Furthermore, based on its advantageous properties as a cell carrier, new applications to support in-vivo and ex-vivo cell expansion have been reported recently. Summary: LSCD constitutes a general indication for AMT. Based on the clinical scenario, AMT may be performed alone to support regeneration of LESCs, in combination with other surgical techniques, or even supporting the in-vivo or ex-vivo expansion of LESCs.

Original languageEnglish (US)
Pages (from-to)363-369
Number of pages7
JournalCurrent Opinion in Ophthalmology
Volume28
Issue number4
DOIs
StatePublished - Jul 1 2017

Fingerprint

Amnion
Stem Cells
Transplantation
Epithelial Cells
Regeneration
Emergencies
Membranes

Keywords

  • amniotic membrane transplantation
  • limbal stem cell deficiency
  • simple limbal epithelial transplantation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Amniotic membrane use for management of corneal limbal stem cell deficiency. / Sabater, Alfonso L.; Perez Quinones, Victor L.

In: Current Opinion in Ophthalmology, Vol. 28, No. 4, 01.07.2017, p. 363-369.

Research output: Contribution to journalReview article

Sabater, Alfonso L. ; Perez Quinones, Victor L. / Amniotic membrane use for management of corneal limbal stem cell deficiency. In: Current Opinion in Ophthalmology. 2017 ; Vol. 28, No. 4. pp. 363-369.
@article{07c69feec2a743df9cef26434ecbc373,
title = "Amniotic membrane use for management of corneal limbal stem cell deficiency",
abstract = "Purpose of review: The current article reviews the most recent surgical techniques for management of corneal limbal stem cell deficiency (LSCD) using amniotic membrane tissue. Recent findings: Early successes with amniotic membrane transplantation (AMT) for the treatment of ocular surface disorders have encouraged clinicians to investigate new applications. The use of AMT as a temporary patch in emergency cases in which LSCD may develop has considerably improved the prognosis of these patients. Amniotic membrane does not have stem cells of its own, but it supports regeneration of limbal epithelial stem cells (LESCs). Similarly, the combination of AMT with classic surgical techniques has enhanced the surgical success rates in most case series. Furthermore, based on its advantageous properties as a cell carrier, new applications to support in-vivo and ex-vivo cell expansion have been reported recently. Summary: LSCD constitutes a general indication for AMT. Based on the clinical scenario, AMT may be performed alone to support regeneration of LESCs, in combination with other surgical techniques, or even supporting the in-vivo or ex-vivo expansion of LESCs.",
keywords = "amniotic membrane transplantation, limbal stem cell deficiency, simple limbal epithelial transplantation",
author = "Sabater, {Alfonso L.} and {Perez Quinones}, {Victor L}",
year = "2017",
month = "7",
day = "1",
doi = "10.1097/ICU.0000000000000386",
language = "English (US)",
volume = "28",
pages = "363--369",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Amniotic membrane use for management of corneal limbal stem cell deficiency

AU - Sabater, Alfonso L.

AU - Perez Quinones, Victor L

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Purpose of review: The current article reviews the most recent surgical techniques for management of corneal limbal stem cell deficiency (LSCD) using amniotic membrane tissue. Recent findings: Early successes with amniotic membrane transplantation (AMT) for the treatment of ocular surface disorders have encouraged clinicians to investigate new applications. The use of AMT as a temporary patch in emergency cases in which LSCD may develop has considerably improved the prognosis of these patients. Amniotic membrane does not have stem cells of its own, but it supports regeneration of limbal epithelial stem cells (LESCs). Similarly, the combination of AMT with classic surgical techniques has enhanced the surgical success rates in most case series. Furthermore, based on its advantageous properties as a cell carrier, new applications to support in-vivo and ex-vivo cell expansion have been reported recently. Summary: LSCD constitutes a general indication for AMT. Based on the clinical scenario, AMT may be performed alone to support regeneration of LESCs, in combination with other surgical techniques, or even supporting the in-vivo or ex-vivo expansion of LESCs.

AB - Purpose of review: The current article reviews the most recent surgical techniques for management of corneal limbal stem cell deficiency (LSCD) using amniotic membrane tissue. Recent findings: Early successes with amniotic membrane transplantation (AMT) for the treatment of ocular surface disorders have encouraged clinicians to investigate new applications. The use of AMT as a temporary patch in emergency cases in which LSCD may develop has considerably improved the prognosis of these patients. Amniotic membrane does not have stem cells of its own, but it supports regeneration of limbal epithelial stem cells (LESCs). Similarly, the combination of AMT with classic surgical techniques has enhanced the surgical success rates in most case series. Furthermore, based on its advantageous properties as a cell carrier, new applications to support in-vivo and ex-vivo cell expansion have been reported recently. Summary: LSCD constitutes a general indication for AMT. Based on the clinical scenario, AMT may be performed alone to support regeneration of LESCs, in combination with other surgical techniques, or even supporting the in-vivo or ex-vivo expansion of LESCs.

KW - amniotic membrane transplantation

KW - limbal stem cell deficiency

KW - simple limbal epithelial transplantation

UR - http://www.scopus.com/inward/record.url?scp=85018491978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018491978&partnerID=8YFLogxK

U2 - 10.1097/ICU.0000000000000386

DO - 10.1097/ICU.0000000000000386

M3 - Review article

VL - 28

SP - 363

EP - 369

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 4

ER -